Opioid Addiction Prevention Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Nov 15, 2017)
Opioid Addiction Prevention Act of 2017
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
What just happenedDec 13, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Who’s behind it
- Introduced in HouseNov 15, 2017
- Dec 13, 2017Committee
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Federal Government Surveillance Subcommittee - Nov 17, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 15, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Nov 15, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Nov 15, 2017IntroReferralIntro-H
Introduced in House
- Nov 15, 2017IntroReferral1000
Introduced in House